Literature DB >> 20379690

Kinetics of cardiac and vascular remodeling by spontaneously hypertensive rats after discontinuation of long-term captopril treatment.

W A Rocha1, W Lunz, M P Baldo, E B Pimentel, E M Dantas, S L Rodrigues, J G Mill.   

Abstract

Angiotensin-converting enzyme inhibitors reduce blood pressure and attenuate cardiac and vascular remodeling in hypertension. However, the kinetics of remodeling after discontinuation of the long-term use of these drugs are unknown. Our objective was to investigate the temporal changes occurring in blood pressure and vascular structure of spontaneously hypertensive rats (SHR). Captopril treatment was started in the pre-hypertensive state. Rats (4 weeks) were assigned to three groups: SHR-Cap (N = 51) treated with captopril (1 g/L) in drinking water from the 4th to the 14th week; SHR-C (N = 48) untreated SHR; Wistar (N = 47) control rats. Subgroups of animals were studied at 2, 4, and 8 weeks after discontinuation of captopril. Direct blood pressure was recorded in freely moving animals after femoral artery catheterism. The animals were then killed to determine left ventricular hypertrophy (LVH) and the aorta fixed at the same pressure measured in vivo. Captopril prevented hypertension (105 + or - 3 vs 136 + or - 5 mmHg), LVH (2.17 + or - 0.05 vs 2.97 + or - 0.14 mg/g body weight) and the increase in cross-sectional area to luminal area ratio of the aorta (0.21 + or - 0.01 vs 0.26 + or - 0.02 microm(2)) (SHR-Cap vs SHR-C). However, these parameters increased progressively after discontinuation of captopril (22nd week: 141 + or - 2 mmHg, 2.50 + or - 0.06 mg/g, 0.27 + or - 0.02 microm(2)). Prevention of the development of hypertension in SHR by using captopril during the prehypertensive period prevents the development of cardiac and vascular remodeling. Recovery of these processes follows the kinetic of hypertension development after discontinuation of captopril.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20379690     DOI: 10.1590/s0100-879x2010007500023

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  8 in total

1.  Effects of late-onset and long-term captopril and nifedipine treatment in aged spontaneously hypertensive rats: Echocardiographic studies.

Authors:  Julia Zimmer; Christina Hawlitschek; Steffen Rabald; Andreas Hagendorff; Heinz-Gerd Zimmer; Beate Rassler
Journal:  Hypertens Res       Date:  2015-07-16       Impact factor: 3.872

2.  Effects of Losartan and Amlodipine on Left Ventricular Remodeling and Function in Young Stroke-Prone Spontaneously Hypertensive Rats.

Authors:  De-Hua He; Liang-Min Zhang; Li-Ming Lin; Ruo-Bing Ning; Hua-Jun Wang; Chang-Sheng Xu; Jin-Xiu Lin
Journal:  Acta Cardiol Sin       Date:  2014-07       Impact factor: 2.672

3.  Effects of spironolactone in spontaneously hypertensive adult rats subjected to high salt intake.

Authors:  Marcelo Perim Baldo; Divanei Zaniqueli; Ludimila Forechi; Rebeca Caldeira Machado; Sérgio Lamêgo Rodrigues; José Geraldo Mill
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

4.  Systemic arterial hypertension leads to decreased semen quality and alterations in the testicular microcirculation in rats.

Authors:  Lucas Giglio Colli; Larissa Berloffa Belardin; Cinthya Echem; Eliana Hiromi Akamine; Mariana Pereira Antoniassi; Rhayza Roberta Andretta; Lucas Solla Mathias; Stephen Fernandes de Paula Rodrigues; Ricardo Pimenta Bertolla; Maria Helena Catelli de Carvalho
Journal:  Sci Rep       Date:  2019-07-30       Impact factor: 4.379

5.  Effects of Captopril and Losartan on Cardiac Stereology in Rats with Renovascular Hypertension.

Authors:  Ali Akbar Nekooeian; Amin Rasti Pour; Farzaneh Dehghani; Elaheh Mashghoolozekr; Tahereh Esmaeilpour
Journal:  Iran J Med Sci       Date:  2021-05

6.  Antihypertensive and cardioprotective effects of different monotherapies and combination therapies in young spontaneously hypertensive rats - A pilot study.

Authors:  Christina Hawlitschek; Julia Brendel; Philipp Gabriel; Katrin Schierle; Aida Salameh; Heinz-Gerd Zimmer; Beate Rassler
Journal:  Saudi J Biol Sci       Date:  2021-09-08       Impact factor: 4.219

7.  Pirfenidone alleviates cardiac fibrosis induced by pressure overload via inhibiting TGF-β1/Smad3 signalling pathway.

Authors:  Na Li; Weijian Hang; Hongyang Shu; Ning Zhou
Journal:  J Cell Mol Med       Date:  2022-07-21       Impact factor: 5.295

8.  How Effective Is a Late-Onset Antihypertensive Treatment? Studies with Captopril as Monotherapy and in Combination with Nifedipine in Old Spontaneously Hypertensive Rats.

Authors:  Christina Hawlitschek; Julia Brendel; Philipp Gabriel; Katrin Schierle; Aida Salameh; Heinz-Gerd Zimmer; Beate Rassler
Journal:  Biomedicines       Date:  2022-08-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.